Symposium: Infantile Epileptic Spasms Syndrome

Clinical trials and multi-center collaborative prospective cohorts have led to new insights into predictors of treatment response and refinement of Infantile Epileptic Spasms Syndrome (IESS) treatment. Novel research tools and technological advances have uncovered potential neurobiological mechanisms underlying IESS.

Boston Children’s Hospital (BCH) through the Infantile Epileptic Spams Program and other research groups have been at the forefront of the outstanding clinical care and research productivity related to IESS. On October 11, these groups will come together for a symposium to explore the prospects of coordinating our collective efforts more closely to improve outcomes of babies with infantile epileptic spasms.

The event is sponsored by the Intellectual and Developmental Disabilities Center and the Rosamund Stone Zander Translational Neuroscience Center at Boston Children’s Hospital and led by the Department of Neurology’s Chris Yuskaitis and Chellamani Harini, co-leaders of the Infantile Spasms Program at BCH.